Director, Precision Medicine

Position Summary

The Director, Precision Medicine provides strategic leadership for the development and delivery of diagnostic products supporting Precision Medicine therapeutic assets at BMS. This role oversees diagnostic development, validation, and companion diagnostic (CDx) delivery to enable robust patient selection and commercial success. The Director collaborates across the enterprise to align diagnostic strategies with organizational goals, with a strong preference for expertise in immunohistochemistry and pathology assay development.

Major Duties and Responsibilities

• Lead Precision Medicine initiatives on asset development, brand, and translational medicine teams where companion or other in vitro diagnostic (IVD) development is strategic.
• Develop and execute Precision Medicine strategies for IVD programs, including immunohistochemistry, immunoassay, PCR, and next-generation sequencing (NGS) for both tissue and blood-based diagnostics, incorporating bioinformatics approaches.
• Chair Precision Medicine matrix sub-teams to maximize asset value by integrating diagnostic biomarkers into exploratory, clinical, regulatory, and medical/commercial strategies.
• Provide strategic direction for diagnostic business development, including search, evaluation, and transactions for diagnostic partnerships.
• Coordinate activities between internal development/brand teams and external diagnostic partners, ensuring delivery of critical milestones (technical development, validation, clinical validation, regulatory activities).
• Participate in commercial planning and medical strategy related to diagnostic products.
• Serve as an internal and external subject matter expert for Precision Medicine, representing BMS to health authorities, medical customers, and at scientific meetings.
• Acquire and disseminate precision medicine knowledge to support organizational learning and capability building.

Qualifications & Experience

• Advanced technical degree (e.g., MSc, PhD) required.
• 5–7 years' experience in assay and IVD development, including analytical validation, clinical development, manufacturing, regulatory submission (US and global), and commercialization of diagnostics.
• Experience in the diagnostic and pharmaceutical industries, oncology biomarkers, diagnostic business development, and/or laboratory medicine certification (e.g., ASCP) is preferred.
• Broad working knowledge of biomarker and IVD platforms.
• Demonstrated matrix leadership skills and ability to work effectively across multiple disciplines, both internally and externally.